Research Paper Volume 12, Issue 21 pp 22233—22252

Development and validation of a novel prognostic signature in gastric adenocarcinoma

Figure 7. Validation of the signature with the GSE84437 dataset (n = 431). KM survival curves of FOXD2-AS1 (A) and SOX4 (B); (C) Distribution of the ceRNA-based signature scores, lncRNA expression levels and patient survival durations in the GSE84437 validation set. (D) ROC curve analyses based on the signature. (E) KM curves of OS according to the risk score.